Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Endocrinology

  • 1
    News

    Inflammatory markers may explain COVID-19, diabetes dynamic

    April 15, 2020

    Higher levels of markers may signal greater susceptibility to cytokine storm.

  • News

    Dapagliflozin trial in CKD halted because of high efficacy

    March 30, 2020

    An independent data monitoring committee recommended stopping the trial.

  • News

    Larger absolute rivaroxaban benefit in diabetes: COMPASS

    March 29, 2020

    The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients with diabetes and stable disease.

  • News

    Keep calm: Under 25s with diabetes aren’t being hospitalized for COVID-19

    March 26, 2020

    But some are concerned that type 1 diabetes diagnoses are being delayed.

  • News

    FDA advises stopping SGLT2 inhibitor treatment prior to surgery

    March 18, 2020

    The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.

  • 1
    News

    Treating COVID-19 in patients with diabetes

    March 17, 2020

    Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.

  • News

    COVID-19: Extra caution needed for patients with diabetes

    March 17, 2020

    Coexisting heart disease, kidney disease, advanced age, and frailty are likely to further increase the severity of disease.

  • News

    MACE benefits with dapagliflozin improve with disease duration

    March 4, 2020

    Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.

  • 1
    Opinion

    Can this patient get IV contrast?

    March 2, 2020

    Patients with seafood allergy have a higher rate of reactions to iodinated contrast, but not at a higher rate than patients with other food allergies.

  • 1
    News

    Noninjectable modes of insulin delivery coming of age

    February 2, 2020

    Intranasally delivered insulin may also improve neurocognitive function.

Previous1 … 9 10 11 12 13 … 18Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences